Danaher Corporation

DHR

US2358511028

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2026-06-05 pm EDT			5-day change	1st Jan Change
184.30 ^USD	-1.25%		+0.89%	-19.49%

Jun. 03	Dh Masi Finance Inc. Enters into Note Purchase and Guaranty Agreement for Issuance of CHF 2,382,280,000 Senior Notes Guaranteed by Danaher Corporation	CI
Jun. 03	HSBC Adjusts Price Target on Danaher to $230 From $270, Maintains Buy Rating	MT

Danaher Corporation announces Quarterly dividend, payable on July 31, 2026

Published on 05/04/2026

S&P Capital IQ

DANAHER CORPORATION

-1.25%

Danaher Corporation announced Quarterly dividend of USD 0.4000 per share payable on July 31, 2026, ex-date on June 26, 2026 and record date on June 26, 2026.

Latest news about Danaher Corporation

Jun. 03	Dh Masi Finance Inc. Enters into Note Purchase and Guaranty Agreement for Issuance of CHF 2,382,280,000 Senior Notes Guaranteed by Danaher Corporation	CI
Jun. 03	HSBC Adjusts Price Target on Danaher to $230 From $270, Maintains Buy Rating	MT
May. 22	China's commerce ministry holds meeting with foreign pharmaceutical firms	RE
May. 22	Henry Schein Names William K. Daniel as Independent Chairman	MT
May. 21	Oxford Nanopore Technologies Names Chief Medical, Information Officers	MT
May. 15	Danaher Seen on Path to Growth Reacceleration on Bioprocess Recovery, RBC Says	MT
May. 15	Danaher Set for Growth Reacceleration Amid Strong Bioprocessing Trends, RBC Says	MT
May. 13	Danaher Corporation Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 11:20 AM
May. 11	Aldevron co and Minaris renew lentiviral plasmid agreement to accelerate gene-modified cell therapy development	RE
May. 05	Danaher Corp - declares quarterly cash dividend of $0.40 per share payable July 31, 2026	RE
May. 04	Danaher Corporation announces Quarterly dividend, payable on July 31, 2026	CI
May. 04	Masimo Shareholders Approve Acquisition by Danaher	MT
May. 04	Masimo shareholders approve acquisition by Danaher	RE
May. 04	Agilent Technologies Inc. Appoints Michael Buckner as Chief Legal Officer, Effective May 4, 2026	CI
May. 04	Seer, Inc. Appoints Anthony Bazarko as Chief Commercial Officer	CI

Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).

Employees

59,000

Sector

Advanced Medical Equipment & Technology

Calendar

Jun. 26 - Ex-dividend date - 0.4 USD

More about the company